BMRC - Who We Are

Vision

To be a relevant actor in the implementation of research programs, whose results provide solutions to relevant problems in the area of human health.

Mission

How can I increase my chances of winning more at online casinos? There will always be uncertainties when you play games at an online casino canada. Even if you control as many variables as possible, there will always be things out of your control, because as the name implies, these are games of chance. However, that doesn't mean that you can't develop some basic strategies to increase your winning potential at online casinos. Firstly, use basic casino strategies. If you focus on getting the basics right, you will have a better chance when it comes time to play. Collect the best bonuses - online casino bonuses are a safety net. They won't prevent you from losing, but they will be there to catch you if you fall. They won't prevent your losses, but they can help -and a lot- to control your winning and losing potential. Also, choose the right games. Some people do better with slots, others will thrive on blackjack. The goal of online casino games is to find what works best for you. Which games do you like best? What kind of decisions do you make best? And most importantly, which games have the best payout rates? You need to consider these details before you choose a game to start playing for real.

To carry out technological research in the area of human health with applicability and impact in the productive sector.

Promote University-Industry alliances.

Creation of permanent research capacities through:

Training highly qualified staff to contribute to research in the university and the industry.

Creation of infrastructure and acquisition of state-of-the-art equipment for research.

BACKGROUND

BMRC, Biomedical Research Consortium-Chile

BMRC, Biomedical Research Consortium-Chile was set up in 2007 as the result of the association between the Pontificia Universidad Católica de Chile, Recalcine Pharmaceutical Corporation and other important companies in the pharmaceutical area. The objective of this alliance between the private company and the Academy is to develop and generate solutions (product/ technological package) with a high impact on human health through R & D lines, applicable and transferable to the market.

Today the consortium consists of the Universidad Católica and Abbott, a US-based pharmaceutical laboratory that acquired Recalcine as an instrument to access the Latin American market. Both institutions finance the activities of the consortium.

Other relevant actors are a team of six researchers sponsored by the consortium, leaders in their respective areas, with wide national and international recognition, as well as important alliances and collaborations with important research centers in the rest of the world. Finally, the State contributes public funds to the initiative through Corfo, which has replaced the original instrument by Conicyt: Bicentennial Program for Science and Technology. II Business Technological Consorsiums in Research 2005.

The consortium's governance is as follows: an executive team; a board of directors representing the members of the consortium (UC-Abbott); technical, executive and commercial committees; external advisors; and five researchers.